09:45

Dr Burke Pinpoints Top Trends from ASH 2024

05:01

Controversy Over Adjuvant CDK4/6 Inhibitors in HER2-Negative Breast Cancer

03:36

Optimizing Hematologic Care With Real-World Data

03:38

Top Anticipations for ASH 2024: Oncologists Share Key Highlights to Watch

07:52

Initiating The Discussion on Informative Censoring in Clinical Trials

03:18

Expert Takeaway From WCLC Congress Involving Innovative Bispecific Antibody for NSCLC

04:09

AI Model (DeepHRD) Bests Standard Tests in Predicting HRD

03:23

The Impact of Weight-loss Treatments on Cancer in The US

04:14

Oncologists Share Breakthroughs From the 2024 World Conference on Lung Cancer

30:50

Emerging Experts: A Discussion With Tarantino on HER2-Low Breast Cancer and Antibody-Drug Conjugates

06:46

CRISPR Technology Explored in Oncology

09:10

AI Advances Enable Digital Twin as SOC Control in GVHD Clinical Trials

03:11

Navigating the Newly, Revealed World of MDS

03:02

Combining New Therapies and MRD Approaches Across Lymphomas

02:09

Comparing Afami-cel With Existing Treatments in Synovial Sarcoma

01:02

Should Frontline Myeloma Treatment Include a 3- or 4-Drug Regimen?

01:37

Immunotherapy Combinations Improve Survival in Advanced Renal Cell Carcinoma

01:47

Biomarker Testing Varies at Community/Academic Centers for Gastric Cancer

01:45

PSMA-Targeted Therapies in Clinical Development Show Promise for Prostate Cancer

01:05

Exploring the Reasons Why Certain Prostate Cancers Are More Aggressive

01:26

Clinical Trials Look at Promising Treatments in Mantle Cell Lymphoma

01:12

FDA-Approved Oral Hypomethylating Agent Regimen Excites MDS Landscape

00:58

ADAURA Study Demonstrates Promising Efficacy for Osimertinib in EGFR-Mutant NSCLC

00:35

Novel Agents Could Chemoimmunotherapy in Chronic Lymphocytic Leukemia

01:37

TRK Fusions Help to Fulfill Unmet Need in Thyroid Cancer Treatment Landscape

01:07

JAK Inhibitors Appear Hopeful for Transplant-Eligible MPN Patients in Retrospective Data

01:13

Selpercatinib Data Underscore Value of Precision Medicine in RET-Driven Lung Cancer

01:43

CAR T-Cell Therapy Appears Promising for Heavily Pretreated Multiple Myeloma

01:00

New Treatment Regimens Used to Provide Maximum Benefit in Multiple Myeloma

01:25

Hot Topics of Discussion in the Management of Multiple Myeloma

01:58

CheckMate-9ER Proves to be Efficacious in Advanced or Metastatic RCC

01:40

Multiple Myeloma Treatment Paradigm Improved Markedly In Recent Years

01:24

Unmet Needs Remain in the Diffuse Large B-Cell Lymphoma Treatment Paradigm

01:38

Expert Discusses Results of Analysis on Genomic Testing in mCRPC

01:31

Exploring the Tazemetostat Approval in R/R Follicular Lymphoma

01:50

Genetic Testing Should Be Considered for All Patients With Pancreatic Cancer

00:54

Treatment Landscape for Hepatocellular Carcinoma Evolves at Rapid Pace

02:00

Survival Advantage Observed in HER2+Breast Cancer With Brain Metastasis

02:01

CheckMate 9ER Trial Demonstrates Efficacy in Patients With RCC

00:52

Genomic Testing Is Necessary in Non-Small Cell Lung Cancer

01:01

Comparing BTK Inhibitors in Patients With B-Cell Malignancies

01:35

CheckMate-9ER Shows Efficacy of Nivolumab/Cabozantinib Combo in RCC

01:21

Exploring Targeted and CAR T-Cell Therapies on the Horizon for MCL

01:45

ACCC President Highlights Oncology Community Response to COVID-19 Pandemic

01:31

Early Data Presented for Lenvatinib and Pembrolizumab in Thyroid Cancer

01:14

Tafasitamab Plus Lenalidomide Approval Generates Excitement for Second-Line DLBCL

04:48

Novel Therapies in Advanced RCC

05:32

Lenvatinib and Everolimus for Advanced RCC

04:14

Second-Line Treatment Options for Advanced RCC

05:25

Advanced RCC Treatment Selection

06:02

Risk Stratification of Patients With Advanced RCC

03:50

Case Overview: 58-Year-Old Man With Advanced RCC

01:24

Evaluating Next Steps for Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer

01:13

Improving Biomarker Discovery and Development in Urothelial Carcinoma

01:39

Pembrolizumab/Lenvatinib Combo Achieves Promising Responses in Anaplastic Thyroid Cancer

01:38

Clinical Trials Excite Treatment Landscape for Early-Stage EGFR-Mutated NSCLC

01:21

Exploring the Future of CAR T-Cell Therapy in Multiple Myeloma

01:52

HER2CLIMB Regimen Can Be Used Earlier in HER2+ Metastatic Breast Cancer

01:23

Treatment Approaches Become More Individualized as Field of Myelofibrosis Advances

01:23

Improving Upon Immunotherapy Advances in HCC